Furthermore, recent studies have delineated that CGs exhibit an immense potential to directly or indirectly inhibit the activation of the TFs such as NF-κB, FGF-2, STAT-3, HIF-1α, and thus, suppress tumor growth [16,17]. The gene discussed is NFKB1; the disease is neoplasm.